These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30179535)

  • 21. Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993-2014.
    Liang D; Bao Y; Wallace M; Grant I; Shi Y
    Addiction; 2018 Nov; 113(11):2060-2070. PubMed ID: 29989239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Building smart cannabis policy from the science up.
    Weiss SRB; Howlett KD; Baler RD
    Int J Drug Policy; 2017 Apr; 42():39-49. PubMed ID: 28189459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the public health impacts of legalizing recreational cannabis use in the USA.
    Hall W; Weier M
    Clin Pharmacol Ther; 2015 Jun; 97(6):607-15. PubMed ID: 25777798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early-Stage Cannabis Regulatory Policy Planning Across Canada's Four Largest Provinces: A Descriptive Overview.
    Watson TM; Hyshka E; Bonato S; Rueda S
    Subst Use Misuse; 2019; 54(10):1691-1704. PubMed ID: 31076006
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of cannabinoids in post-mortem blood samples from the province of New Brunswick before and after recreational cannabis legalization.
    Jordan A; Sherazi A; Flewelling AJ; Northrup V; Naseemuddin A; Shea JL
    Int J Drug Policy; 2022 May; 103():103629. PubMed ID: 35228057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabis Legalization Does Not Influence Patient Compliance with Opioid Therapy.
    Lo SY; Winston-McPherson GN; Starosta AJ; Sullivan MD; Baird GS; Hoofnagle AN; Greene DN
    Am J Med; 2019 Mar; 132(3):347-353. PubMed ID: 30419224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabis, pesticides and conflicting laws: the dilemma for legalized States and implications for public health.
    Stone D
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):284-8. PubMed ID: 24859075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Societal Costs and Outcomes of Medical and Recreational Marijuana Policies in the United States: A Systematic Review.
    French MT; Zukerberg J; Lewandowski TE; Piccolo KB; Mortensen K
    Med Care Res Rev; 2022 Dec; 79(6):743-771. PubMed ID: 35068253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of Cannabis Legalization on Substance-Related Benefits and Harms for People Who Use Opioids: A Canadian Perspective.
    Bahji A; Socias ME; Bach P; Milloy MJ
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):699-702. PubMed ID: 37001172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis legalization, regulation, & control: a review of key challenges for local, state, and provincial officials.
    Caulkins JP; Kilborn ML
    Am J Drug Alcohol Abuse; 2019; 45(6):689-697. PubMed ID: 31135218
    [No Abstract]   [Full Text] [Related]  

  • 31. The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018.
    Cox C
    Health Policy; 2018 Mar; 122(3):205-209. PubMed ID: 29429644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Legalization as more effective control? Parallels between the end of alcohol prohibition (1927) and the legalization of cannabis (2018) in Ontario, Canada.
    Crépault JF; Rehm J; Room R
    Int J Drug Policy; 2021 Nov; 97():103367. PubMed ID: 34311148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: Findings from state policy evaluations.
    Smart R; Pacula RL
    Am J Drug Alcohol Abuse; 2019; 45(6):644-663. PubMed ID: 31603710
    [No Abstract]   [Full Text] [Related]  

  • 34. Measurement of public health impacts of cannabis legalization in Canada to reflect policy maker priorities: A rapid scoping review of instruments and content domains.
    Lazor T; Blondal E; Scheim A; Cubillos P; Werb D; Milloy MJ; Bonato S; Maghsoudi N; Rueda S
    Drug Alcohol Depend; 2022 Jul; 236():109463. PubMed ID: 35594643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges for Clinical Cannabis and Cannabinoid Research in the United States.
    Cooper ZD; Abrams DI; Gust S; Salicrup A; Throckmorton DC
    J Natl Cancer Inst Monogr; 2021 Nov; 2021(58):114-122. PubMed ID: 34850896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nine Insights From 10 Years of Legal Cannabis for Nonmedical Purposes.
    Kilmer B; Pérez-Dávila S
    Clin Ther; 2023 Jun; 45(6):496-505. PubMed ID: 37414499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recreational Cannabis Use: Regulatory Aspects, Public Opinion and Concerns for Public Health.
    Scopetti M; Padovano M; Peruch M; Concato M; Livieri T; Radaelli D; D'Errico S
    Curr Pharm Biotechnol; 2023; 24(6):728-740. PubMed ID: 35996264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis Legalization and Adolescent Use of Electronic Vapor Products, Cannabis, and Cigarettes.
    Bhatia D; Hinckley J; Mikulich S; Sakai J
    J Addict Med; 2022 Jan-Feb 01; 16(1):e16-e22. PubMed ID: 35120066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in Opioid and Benzodiazepine Poisoning Deaths After Cannabis Legalization in the US: A County-level Analysis, 2002-2020.
    Castillo-Carniglia A; Rivera-Aguirre A; Santaella-Tenorio J; Fink DS; Crystal S; Ponicki W; Gruenewald P; Martins SS; Keyes KM; Cerdá M
    Epidemiology; 2023 Jul; 34(4):467-475. PubMed ID: 36943813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale for cannabis-based interventions in the opioid overdose crisis.
    Lucas P
    Harm Reduct J; 2017 Aug; 14(1):58. PubMed ID: 28821296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.